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Abstract
Background: Visceral leishmaniasis is the most severe form of leishmaniasis. Approximately 20% of zoonotic human visceral
leishmaniasis worldwide is caused by Leishmania infantum, which is also known as Leishmania chagasi in Latin America, and
disease incidence is increasing in urban and peri-urban areas of the tropics. In this form of disease, dogs are the main
reservoirs. Diagnostic methods used to identify Leishmania infected animals are not able to detect all of the infected ones,
which can compromise the effectiveness of disease control. Therefore, to contribute to the improvement of diagnostic
methods for canine visceral leishmaniasis (CVL), we aimed to identify and test novel antigens using high-throughput
analysis.
Methodology/Principal Findings: Immunodominant proteins from L. infantum were mapped in silico to predict B cell
epitopes, and the 360 predicted peptides were synthesized on cellulose membranes. Immunoassays were used to select the
most reactive peptides, which were then investigated with canine sera. Next, the 10 most reactive peptides were
synthesized using solid phase peptide synthesis protocol and tested using ELISA. The sensitivity and specificity of these
peptides were also compared to the EIE-LVC Bio-Manguinhos kit, which is recommended by the Brazilian Ministry of Health
for use in leishmaniasis control programs. The sensitivity and specificity of the selected synthesized peptides was as high as
88.70% and 95.00%, respectively, whereas the EIE-LVC kit had a sensitivity of 13.08% and 100.00% of specificity. Although
the tests based on synthetic peptides were able to diagnose up to 94.80% of asymptomatic dogs with leishmaniasis, the EIE-
LVC kit failed to detect the disease in any of the infected asymptomatic dogs.
Conclusions/Significance: Our study shows that ELISA using synthetic peptides is a technique with great potential for
diagnosing CVL; furthermore, the use of these peptides in other diagnostic methodologies, such as immunochromato-
graphic tests, could be beneficial to CVL control programs.
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Introduction
Leishmaniasis, which is one of the major parasitic diseases
recognized by the World Health Organization, affects approximately
1–2 million individuals annually. Dogs are considered the main
domestic reservoir of Leishmania infantum (also known as L. chagasi)[ 1 ] ,
which is the causative agent of zoonotic visceral leishmaniasis (VL) in
both the Old and New Worlds [2]. In endemic areas, up to 85% of
infected dogs may be asymptomatic [3], and they serve as reservoir
for vector transmission to susceptible animals and humans [4].
The epidemiological control of VL in Brazil involves the
elimination of infected dogs, widespread insecticide use and the
systematic treatment of human cases [5]. Reliable diagnostic tests
for L. infantum detection are essential to prevent disease
transmission and the unnecessary culling of dogs. Given the
frequency of asymptomatic infections in dogs and the difficulty of
direct parasite detection, the development of rapid and accurate
indirect diagnostic methods for canine infection is essential for VL
surveillance programs. The principal serodiagnostic tests include
the immunofluorescent antibody test (IFAT) and the enzyme-
linked immunosorbent assay (ELISA). These conventional tests
employ crude antigen preparations of either whole promastigotes
or their soluble extracts, which limits assay standardization and
result reproducibility [6].
An alternative method for the production of antigens for
immunoassays is the synthesis of peptides. These peptides are
relatively simple to synthesize and are cheaper to produce
compared to the production of whole proteins [7]. In general,
the use of synthetic peptides increases the specificity of
immunoassays compared to crude antigens [8].
www.plosntds.org 1 September 2011 | Volume 5 | Issue 9 | e1310In previous studies, we identified almost 50 immunodominant
proteins of L. infantum, mapped their B cell epitopes and submitted
180 peptides to Spot synthesis and immunoassay. A total of 25
peptides showed promising characteristics for serodiagnosis of
visceral leishmaniasis [9]. Here, we increased the B cell epitopes
mapping, performed a high-throughput analysis of 360 peptides
and selected the top 10 peptides for ELISA testing. When assessed,
the specificity and sensitivity of the selected peptides was as high as
88.7% and 95.0%, respectively. These new antigens represent
solid candidate peptides for the diagnosis of VL with great
accuracy, especially in asymptomatic animals.
Methods
Ethics Statement
Experiments with dogs were performed in compliance with the
guidelines of the Institutional Animal Care and Committee on
Ethics of Animal Experimentation (Comite ˆd eE ´tica em Experi-
mentac ¸a ˜o Animal – CETEA, national guidelines Lei 11.794, de 8
de outubro de 2008) from Universidade Federal de Minas Gerais
(UFMG); protocol 211/07 was approved on 03/12/2008.
Canine Sera
For the initial screening of Leishmania antigens on cellulose
membranes, we used a pool of sera from ten animals per
experimental group, i.e., chronically infected dogs and uninfected
control dogs. The chronically infected dogs were naturally infected
with Leishmania, and they were found in the metropolitan region of
Belo Horizonte, Minas Gerais state, Brazil, rescued and
maintained in our facility for laboratory and clinical evaluations.
VL in chronically infected dogs was certified by the presence of
clinical symptoms and parasitological tests that were conducted on
bone marrow cells examined by optical microscopy. The
uninfected dogs were negative based on parasitological as well as
serological tests for VL; these animals served as negative controls
in our study. Blood from all the dogs was withdrawn and
maintained at room temperature for 3 h to obtain serum. For each
animal in a group, 100 mL of serum was deposited in a single tube
to obtain a pool of sera that was representative of chronically
infected or uninfected dogs; each group was comprised of 10 dogs.
For the ELISA tests, we used the serum described above and 62
serum samples from 23 symptomatic and 39 asymptomatic dogs from
Pancas, Espı ´rito Santo state, Brazil. Dogs were scored for 6 typical
signs of canine visceral leishmaniasis: alopecia, dermatitis, chancres,
conjunctivitis, onychogryphosis and lymphadenopathy. Each sign
was scored on a semi-quantitative scale from 0 (absent) to 3 (severe),
and these scores were added together to give an overall clinical score.
Dogs with a total score of 0-2 were arbitrarily classed as
asymptomatic, 3-6 as oligosymptomatic and 7-18 as symptomatic
[10]. Additionally, several serum samples from dogs that were
experimentally infected with other pathologies were also tested;
samples from dogs that were seropositive for Trypanosoma cruzi by RIFI
(n=15) and positive for Leishmania braziliensis based on parasitological
examination and molecular identification (n=20) were kindly
provided by Prof Dr. Ricardo Toshio Fujiwara of UFMG and Prof
Dr. Alexandre Barbosa Reis of UFOP, respectively.
Epitope Identification and Spot Synthesis
Previously, we identified almost 50 immunodominant proteins
from L. infantum, performed the mapping of their B cell epitopes
using BepiPred program that is based on propensity scale methods
(http://www.cbs.dtu.dk/services/BepiPred/[11]), and a total of
180 peptides were submitted for Spot synthesis and immunoassays,
and 25 peptides were shown to be of interest for use in VL
serodiagnosis [9]. Here, we completed the mapping of the same
proteins [9] using two different programs: ABCPred, based on
machine learning methods that apply a recurrent neural network
(http://www.imtech.res.in/raghava/abcpred [12]) and BCPreds,
which is also based on machine learning methods but involve those
that apply a support vector machine (http://ailab.cs.iastate.edu/
bcpreds/[13]). Epitopes that were predicted by the two programs
simultaneously (excluding those previously identified [9]) were
synthesized using the Spot synthesis method [14] on derivatized
cellulose membranes with an Ala-Ala linker; peptide size ranged
from 9 to 14 amino acids [15].
Immunoassays with cellulose-bound peptides
Initially, the selection of the most immunoreactive peptides was
performed using immunoassays of pooled canine serum (previ-
ously described in [9]) and alkaline phosphatase-conjugated goat
anti-dog immunoglobulin G. We tested all of the peptides mapped
in both studies. The relative intensity of the spots representing
each peptide was determined by overlapping positive and negative
membranes with ImageMaster
TM Platinum program. Peptides
with relative intensity values of 2 or greater (RI $ 2) were
considered potential candidate antigens [16]. Next, new mem-
branes were synthesized with only the selected peptides, and they
were tested with individual canine sera. To evaluate these assays,
cut off values were calculated for each peptide using the mean
color intensity + 2 standard deviations (SD) from 5 known negative
individual canine sera. All assays were performed in duplicate.
Synthesis of soluble peptides
Based on the results of immunoassays conducted using cellulose-
bound peptides that were probed with canine sera, 10 peptides
that exhibited reactivity with the largest number of serum
samples from infected animals were chemically synthesized using
9-florenyl-methoxy-carbonyl (Fmoc) chemistry [17] in an auto-
mated synthesizer, model PSSM8 (Shimadzu, Kyoto, Japan).
Peptide purity was assessed with reverse-phase high perfor-
mance liquid chromatography (HPLC) and mass spectrometry
(MALDI-TOF-TOFAutoFlexIII
TM, BrukerDaltonics, Billerica,
Author Summary
Globally, the number of new human cases of visceral
leishmaniasis (VL) is estimated to be approximately
500,000 per year. This is the most severe of all forms of
leishmaniasis, and the zoonotic form of VL, caused by
Leishmania infantum (also known as Leishmania chagasi),
represents 20% of human visceral leishmaniasis worldwide;
additionally, its prevalence is increasing in urban and peri-
urban areas of the tropics. In Brazil, the identification and
elimination of infected dogs, which act as a reservoir for
Leishmania parasites, is a control measure employed in
addition to the use of insecticides against the vectors and
the identification and treatment of infected humans.
Currently, the diagnostic methods employed to identify
infected animals are not able to detect all of these dogs,
which compromises the effectiveness of control measures.
Moreover, one of the most important issues in controlling
VL is the difficulty of diagnosing asymptomatic dogs,
which act as parasite reservoirs. Therefore, to contribute to
the improvement of the diagnostic methods for CVL, we
aimed to identify and characterize new antigens that were
more sensitive and specific and could be applied in
epidemiologic surveys.
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and used as antigens in ELISA assays.
ELISA
All ELISA procedures were optimized in terms of antigen
concentrations and the dilutions of serum and conjugated
immunoglobulins to develop a reproducible and robust assay.
The optimal antigen concentration was 20mg/mL. A clear
separation between sera from L. infantum-infected and uninfected
animals was possible using 1:100 dilutions for sera and 1:5,000
dilutions for the conjugated immunoglobulins.
Falcon flexible microtitration plates purchased from Becton
Dickinson Labware Europe (Becton Dickinson, France S.A.) were
coated for 16 h approximately with 100 mL/well of synthetic
peptides (20 mg/mL) in PBS. Wells were then blocked with 5%
powdered skim milk in PBS/T (PBS containing 0.05% Tween20)
at 37uC for 1 hour. Serum samples, diluted 1:100 in PBS/T
containing 0.5% powdered skim milk, were added and incubated
at 37uC for 1 hour. Plates were washed three times with PBS/T
and then incubated with peroxidase-conjugated anti-dog immu-
noglobulin G (Sigma-Aldrich, St. Louis, MO) diluted 1:5,000 in
PBS/T containing 0.5% powdered skim milk at 37uC for 1 h.
After washing three times with PBS/T, reactions were developed
with Fast-OPD
TM (Sigma-Aldrich, St. Louis, MO). Plates were
incubated for 30 min in the dark. The reactions were stopped with
2MH 2SO4, and the plates were read at 492 nm in a Multiskan
Plate Reader (MCC/340).
The results of the ELISA using synthetic peptides as antigens
(EP) were compared with those obtained with the EIE-LVC Bio-
Manguinhos kit, which is based on immunoenzymatic detection of
canine visceral leishmaniasis. The EIE-LVC Bio-Manguinhos kit
uses crude antigens and is currently recommended by the
Brazilian Ministry of Health for the screening of seroreactive
animals [18]. To do this comparison, the same serum samples
were tested using both assays; the EIE-LVC kits were used
according to the manufacturer’s instructions and also calculating a
different cut off, employing ROC curve and the same control
serum samples already described.
Statistical analysis
A cut off point for optimal sensitivity and specificity was
determined using ROC analysis [19], and the area under the
curve (AUC) was calculated to assess the performance of the tests.
All of the statistical analyses were performed using GraphPad
Prism
TM (version 5.0) and MedCalc
TM (version 7.3).
Agreement beyond chance between the tests was assessed using
the Cohen Kappa (k) coefficient [20] and interpreted according to
the following scale: 0.00–0.20, negligible; 0.21–0.40, weak; 0.41–
0.60, moderate; 0.61–0.80, good and 0.81–1.00, excellent [21].
The accuracy of each test was evaluated according to the AUC
referent to the ROC curve and the Youden index J [22].
Results
Epitope identification, Spot synthesis and immunoassays
with cellulose-bound peptides
ABCPred and BCPreds programs simultaneously predicted 191
distinct peptides. However, 11 peptides predicted by both
programs were previously predicted by BepiPred [9]. All of these
peptides (n=360) were synthesized in cellulose membranes and
submitted to immunoassays. Among these 360 peptides, there
were 48 with RI $ 2, which are presented in Table S1.
All of the 48 selected peptides were synthesized onto new
cellulose membranes and subjected to immunoassays with
individual canine serum samples obtained from 5 uninfected dogs
and 20 L. infantum-infected dogs. The pattern of recognition of the
various serum samples was similar against the same peptide;
furthermore, uninfected serum samples always showed lower
reactivity compared to serum samples from infected animals. In
this step, peptides that were reactive with pooled sera from
T. cruzi-infected animals were excluded (data not shown).
Ten peptides were reactive against multiple individual canine
serum samples (from 35% to 75% of samples) and also did not
cross-react with pooled sera from T. cruzi-infected animals
(presented in Table S2). Coincidently, these 10 peptides resulted
from the simultaneous prediction by two programs (ABCPred and
BCPreds). These peptides were then synthesized in a soluble form
using solid phase technique to be used in ELISA tests.
ELISA
The antigens (peptides) selected for ELISA testing were named
as follows: PSLc1, PSLc2, PSLc3, PSLc4, PSLc5, PSLc6, PSLc7,
PSLc8, PSLc9 and PSLc10. All of the peptides were mixed into a
single solution (Mix10), which was used as another antigen in
ELISA testing.
Peptide sensitivity and specificity were calculated using
parasitological results as a gold standard. Most of the peptides
were able to detect a large percentage of symptomatic and
asymptomatic infected dogs, which was not observed with
EIE-LVC kit. Diagnostic performances of the EP and EIE-LVC
kit for canine serum samples are shown in Table 1. Based on the
accuracy of the EP, those peptides with higher AUC and Youden
index J values were selected. Thus, PSLc6, PSLc8 and PSLc10, as
well as the Mix10, were tested again with a higher number of
serum samples.
The next stage of testing was performed with 107 serum samples
from L. infantum-infected dogs and the same 20 serum samples that
were used as the negative controls in the previous assays.
Additionally, 15 serum samples from T. cruzi-infected dogs and
20 from L. braziliensis-infected dogs were also tested. Figure 1
shows the results obtained with the three selected peptides and the
Mix10 tested separately. Some cross-reactivity with T. cruzi and
L. braziliensis occurred for all of the antigens, being cross-reactivity
with L. braziliensis more frequent. For PSLc6, 40% of T. cruzi and
70% of L. braziliensis-infected serum samples were considered
positive (Figure 1A). PSLc8 exhibited cross-reactivity with 26.6%
of T. cruzi and 85% of L. braziliensis-infected serum samples
(Figure 1B), whereas 93.3% of T. cruzi and 95.0% of L. braziliensis-
infected samples reacted with PSLc10 (Figure 1C). Mix10 showed
a similar pattern, with 80% of T. cruzi-infected serum samples and
70% of L. braziliensis-infected serum samples testing positive
(Figure 1D).
The same serum samples were tested using the kit recom-
mended by the Brazilian Ministry of Health (EIE-LVC kit). The
cut off value obtained as recommended by manufacturer (negative
control absorbance multiplied by two) was very high, and was
therefore outside the detection range for many of the infected dogs
(Figure 2A). Furthermore, when ROC curve was applied using the
previous described control serum samples, the cut off obtained was
lower, which increased sensitivity, but cross-reactivity occurred
with 53.3% of T. cruzi infected sera and with 40.0% of L. braziliensis
infected sera (Figure 2B).
The sensitivity, specificity, AUC and Youden index J values
were calculated for the investigated serological tests (Table 2). The
sensitivity of the widely used EIE-LVC kit performed according to
the manufacturer was 13.08%, but when ROC curve was applied
to calculate cut off value, the sensitivity was 87.85%. EP showed
sensitivities that ranged between 71.03% and 84.10%, depending
Synthetic Peptides in CVL Diagnosis
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AUC value (0.902), showing a high accuracy [23], followed by the
EP PSLc10 with an AUC value of 0.888. The Youden index
J values for these two tests were also the highest, with values of
0.585 and 0.641, for the EP Mix10 and EP PSLc10, respectively.
Specificity rates were determined for all uninfected dogs. The
specificity of the kit was 100%, as a result of the high cut off value.
In contrast, the specificity of EP ranged from 55% to 80%,
depending on the peptide used.
When the ROC curves obtained from all of the investigated
tests with synthetic peptides were combined, it was possible to
observe that EP PSLc6 had the lowest AUC value, showing the
Table 1. Diagnostic performance of EP and EIE-LVC kit in serum samples from symptomatic and asymptomatic dogs.
Antigen/test Se % Sp % AUC Youden index J Sym + (%) Asym + (%) Total+ (%)
PSLc1 72.50 75.00 0.754 0.475 17 (73.9%) 28 (71.7%) 45 (72.5%)
PSLc2 75.80 70.00 0.769 0.458 16 (69.5%) 31 (79.4%) 47 (75.8%)
PSLc3 74.10 70.00 0.778 0.441 22 (95.6%) 24 (61.5%) 46 (74.1%)
PSLc4 75.80 70.00 0.797 0.458 11 (47.8%) 36 (92.3%) 47 (75.8%)
PSLc5 70.96 55.00 0.642 0.259 16 (69.5%) 28 (71.7%) 44 (70.9%)
PSLc6 79.00 85.00 0.904 0.64 16 (69.5%) 33 (84.6%) 49 (79.0%)
PSLc7 85.40 80.00 0.863 0.654 19 (82.6%) 34 (87.1%) 53 (85.4%)
PSLc8 82.26 95.00 0.944 0.772 17 (73.9%) 34 (87.1%) 51 (82.2%)
PSLc9 79.00 75.00 0.847 0.540 12 (52.1%) 37 (94.8%) 49 (79.0%)
PSLc10 88.70 85.00 0.947 0.737 20 (86.9%) 35 (89.7%) 55 (88.7%)
Mix10 75.81 95.00 0.916 0.708 13 (56.5%) 34 (87.1%) 47 (75.8%)
EIE-LVC kit
* 8.00 100.00 NA 0.08 5 (21.7%) 0 (0%) 5 (8.0%)
Samples from symptomatic (n=23), asymptomatic (n=39) L. infantum-infected dogs and healthy dogs (n=20) were tested. Se: sensitivity; Sp: specificity; Sym: number
of symptomatic dogs diagnose as positive; Asym: number of asymptomatic dogs diagnose as positive;
*cut off obtained according to the manufacturer.
doi:10.1371/journal.pntd.0001310.t001
Figure 1. Comparison of ELISA reactivity of canine sera against PSLc6, PSLc8, PSLc10 and Mix10. ELISA was performed in different
groups of dogs (C, control group, n=20; CVL, L. infantum group, n=107; TC, T. cruzi group, n=15; LB, L. braziliensis group, n=20) against PSLc6 (A),
PSLc8 (B), PSLc10 (C) and Mix10 (D).
doi:10.1371/journal.pntd.0001310.g001
Synthetic Peptides in CVL Diagnosis
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other tests presented similar performances, showing overlapping
ROC curves (Figure 3).
A good agreement beyond chance (k index) ranging from 0.402
to 0.751 was obtained when the results from each peptide (PSLc6,
PSLc8, PSLc10) and Mix10 were cross-tabulated (Table 3).
Among these results, the k index value for PSLc6 and Mix10
was the lowest (0.402), showing weak agreement. The correlation
between PSLc8 and Mix10 had the highest k index value (0.751),
showing a good agreement. When the EIE-LVC kit performed
according to the manufacturer was cross-tabulated with the
synthetic peptides, the agreement was very poor. The index
ranged between 0.031 (compared to Mix10) to 0.064 (compared to
PSLc8). All of these correlations indicate a negligible agreement
between these tests. When EIE-LVC kit performed using ROC
curve and 20 control serum samples was cross-tabulated with the
synthetic peptides, the agreement was weak. It ranged from 0.213
(compared to PSLc6) to 0.406 (compared to PSLc10).
Discussion
Despite the efforts to search for new diagnostic methods, a
method with satisfactory CVL diagnosis efficiency is not yet
available. The use of accurate methods that are easy use in the
field and are cheap is crucial for diagnosis and consequently, for
disease control. Therefore, the identification of new antigens is an
important research area for VL disease control. In this work, new
antigens for CVL serological diagnosis were investigated using
bioinformatic tools and successive screenings with immunoassays.
Using bioinformatics, 360 epitopes were predicted from 47
immunogenic proteins that were identified by bidimensional
electrophoresis and Western blot [9]. B cell prediction showed
great efficiency because, in the immunoassays, the majority of the
cellulose-bound peptides were immunogenic. Of the 48 peptides
that could be used to differentiate infected and uninfected dogs, we
selected the ten most specific ones.
The ten best peptides resulted from the prediction of two
programs simultaneously (BCPreds and ABCPred), and none
resulted from using BepiPred considering 2 as a minimum score.
However, we observed that 60% of the ten best peptides were also
predicted as epitopes based on BepiPred’s default score (0.35).
These results suggest that using the default score of prediction
programs associated with the overlapping predictions by more than
one program can be better than using a single type of prediction.
Several authors have already shown that combined T cell epitopes
generated using consensus predictions are believed to be more
accurate [24,25]. It is important to mention that ABCPred and
BCPreds approaches are similar (machine learning methods),
whereas the BepiPred approach is based on propensity scale
methods. This difference could potentially explain the differences
between the epitope predictions made by BepiPred alone compared
to those made by the ABCPreds and BCPreds programs together.
After the immunoassays in cellulose membranes, the ten
peptides that reacted with multiple tested serum samples were
Figure 2. Comparison of ELISA reactivity of canine sera assessed by EIE-LVC kit. ELISA was performed in different groups of dogs
(C, control group, n=1, given by the kit; CVL, L. infantum group, n=107; TC, T. cruzi group, n=15; LB, L. braziliensis group, n=20). In A, cut off was
performed according to the manufacturer; in B, it was performed using ROC curve with serum samples from control group.
doi:10.1371/journal.pntd.0001310.g002
Table 2. Diagnostic performance of EP and EIE-LVC kit in a larger panel of canine serum samples.
Serological test Sensitivity in CVL group % (95% CI) Specificity in control group % (95% CI) AUC Youden index J
EP PSLc6 71.03 (61.4–79.3) 55.0 (31.5–76.9) 0.661 0.260
EP PSLc8 81.3 (72.6–88.1) 70.0 (45.7–88.1) 0.876 0.513
EP PSLc10 84.1 (75.7–90.4) 80.0 (56.3–94.2) 0.888 0.641
EP Mix10 78.5 (69.5–85.8) 80.0 (56.3–94.2) 0.902 0.585
EIE-LVC kit
* 13.08 (7.3–20.9) 100.0 (2.5–100.0) NA 0.130
EIE-LVC kit
# 87.85 (80.12– 93.3) 75.0 (50.9–91.3) 0.848 0.620
Samples from L. infantum-infected dogs (n=107) and healthy dogs (n=20) were tested. CI: confidence interval; AUC: area under the curve; NA: not applicable;
*cut off obtained according to the manufacturer;
#cut off obtained by ROC curve using 20 control serum samples.
doi:10.1371/journal.pntd.0001310.t002
Synthetic Peptides in CVL Diagnosis
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reactivity as antigens and were able to recognize specific
antibodies in ELISA. The performance observed for the new
antigens presented in this work (maximum of sensitivity and
specificity of approximately 84.1% and 80.0% respectively) is
compatible with the performance of many antigens, mainly
recombinant proteins, that have been developed in recent years
for CVL diagnosis [26-28] with the advantage of being cheaper
and faster to produce.
However, there are other ELISA methods described for CVL
that have greater sensitivity or specificity compared to EP. A study
conducted in Brazil investigated sera from negative controls (n=30)
and from L. infantum-infected dogs (n=60) in a fucose-mannose
ligandbasedELISA.UsingROCcurve,the sensitivitywas90%and
specificity was 93.3% in oligosymptomatic dogs [29]. Another
Brazilian study analyzed 209 sera samples from L. infantum-infected
dogs in a recombinant cysteine proteinase based ELISA. The cut off
value was obtained by adding two standard deviation values to the
mean absorbance of 22 sera samples from healthy dogs. It provided
values of 98% and 96% from sensitivity and specificity respectively
[30]. In Europe, some researchers investigated soluble antigens
derived from promastigote or amastigote-like stages of L. infantum
in ELISA. The cut off value was the arithmetic mean plus 3
standard deviations of 48 negative controls. When a group of 47 L.
infantum-infected dogs was tested, sensitivity varied from 94.1 to
100%, and specificity varied from 96 to 100% [31]. All of these
findings show that much has been done to improve CVL diagnosis,
but the results are similar. Higher values of sensitivity and specificity
are motivations for our antigen improvement.
We compared the results obtained in EP with those obtained
with the widely used kit recommended by the Brazilian Ministry of
Health, the EIE-LVC kit. Evaluation of EIE-LVC kit, used as
recommended by manufacturer, revealed a sensitivity of 13.08%
and a specificity of 100%. This low sensitivity could be explained
by the high cut off value, which missed many infected dogs.
However, following this manufacturer’s instruction, test accuracy
is related to the composition of only one negative control provided
by the kit. Then, we used also 20 serum samples from known
uninfected dogs, and the cut off values were obtained using ROC
curves. This way, it was possible to obtain sensitivity of 87.8% and
specificity of 75.0%. The performance of this kit, when evaluated
by other authors is variable. Values of sensitivity of approximately
87.5% and specificity of approximately 100% were obtained
elsewhere; 15 false negative results were reported, being 11 in
asymptomatic dogs, in a group of 120 samples. Therefore, the
prevalence of CVL was underestimated [32]. However, using the
same kit, another study showed a sensitivity of 72% and a
specificity of 87.5%. These authors indicated the use of EIE-LVC
kit in parallel with another kit produced by Bio-Manguinhos,
which employed indirect immunofluorescence, to minimize the
number of false negatives [33].
Previous data have shown that serologic test performance in
CVL depends on infection status [34,35] and an important
limitation in CVL control programs is the inability to identify
Figure 3. Comparison of ROC curves obtained from all the tests. The curves were used to determine ELISA cut off, sensitivity, specificity
and AUC.
doi:10.1371/journal.pntd.0001310.g003
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ly sensitive [36]. Thus, a sensitive and specific antigen for the
detection of asymptomatic dogs would be highly desirable because
it would allow for effective control intervention in areas where
CVL occurs. In our tests, the EIE-LVC kit was not able to detect
any of the 39 serum samples from asymptomatic dogs, while the
new antigens exhibited strong reactivity to the tested sera. For
example, in symptomatic dogs, positive reactions reached up to
95.6% and in asymptomatic dogs, reached up to 94.8%,
depending upon the used peptide.
Among the tested peptides, PSLc6, PSLc8, PSLc10 and Mix10
showed the highest accuracies when tested with serum samples
from animals with defined clinical statuses. Thus, they were
selected to be tested with more serum samples. Then, we observed
that EP Mix10 showed the best performance, with an AUC of
0.902, characterizing the test as highly accurate. EP PSLc8 and EP
PSLc10 had AUC values that characterized these tests as
moderately accurate; only PSLc6 generated a test with low
accuracy. The highest value of sensitivity (84.1%) also was
obtained when PSLc10 was used as antigen. In a canine
epidemiological screening, a test with high sensitivity is desirable.
In addition, all of the EP assays showed a good agreement
according to the k index, when they were cross-tabulated.
However, when the EP tests were cross-tabulated with the
EIE-LVC kit, the agreement was poor in both situations: as
performed according to the manufacturer, it was negligible and as
performed with our control serum samples, it was weak. It could
be explained mainly by the different antigens employed in the
tests. The EP appeared to be more sensitive, once it uses synthetic
peptide while the EIE-LVC kit employs crude antigen. Thus, even
using the ROC curve, the agreement still remained weak between
EIE-LVC kit and EP tests.
The occurrence of cross-reactivity with T. cruzi and L. braziliensis
in EP were observed with all synthetics antigens. These results
corroborate other researchers’ findings concerning to new antigens
in CVL diagnosis [26,27,37,38]. In all of them, some cross-
reactivity with these parasites occurred.
Although there has been speculation on the role of dogs in the
zoonotic cycle of tegumentary leishmaniasis (TL) caused by
L. braziliensis, only circumstantial evidence supports this hypothesis
[39]. Indeed, the primary reservoirs of L. braziliensis are small
mammals, particularly wild rodents [40], making the importance
of this kind of cross-reactivity in the diagnosis of CVL
controversial. Therefore, it could be considered that TL infected
dogs have low antibodies levels similar to human TL infections.
Some authors described the immune response in human TL
infection as predominantly cellular, with low levels of circulating
antibodies [41].
Importantly, canine infection with L. braziliensis is associated
with rural areas. Our test has been developed with the intention of
being used in urban surveys, as a diagnostic tool in the control of
urban LV. Besides, the prevalence rates of L braziliensis in dogs are
low (3.1%), when parasitological examination was performed in
Brazil [42]. About the prevalence of T. cruzi in dogs, few data have
been published. In a study conducted with 244 dogs in nine
municipalities in Parana ´ state, Brazil, no dogs were found to be
Table 3. Kappa index (k) between paired results of diagnostic tests.
Serological test Serological test
EIE-LVC kit
* EP PSLc6 EP PSLc8 EP PSLc 10 EP Mix10
P( +)N ( 2)T P ( +)N ( 2)T P ( +)N ( 2)T P ( +)N ( 2)T P ( +)N ( 2)T
EIE-LVC kit
# P(+) 14 87 101 73 28 101 81 20 101 84 17 101 76 25 101
N(-) 0 2 6 2 6 1 2 1 4 2 6 1 21 4 2 6 1 01 62 6 1 21 42 6
T 14 113 127 85 42 127 93 34 127 94 33 127 88 39 127
k index (95% CI) 0.062 (-0.049–0.172) 0.213 (0.011–0.415) 0.306 (0.097–0.514) 0.406 (0.208–0.605) 0.245 (0.041–0.450)
EP Mix10 P(+) 11 77 88 70 18 88 84 4 88 81 7 88 -
N(-) 3 36 39 15 24 39 9 30 39 13 26 39
T 14 113 127 85 42 127 93 34 127 94 33 127
k index (95% CI) 0.031 (-0.098–0.161) 0.402 (0.227–0.578) 0.751 (0.622–0.878) 0.613 (0.458–0.769)
EP PSLc 10 P(+) 13 81 94 75 19 94 85 9 94 - -
N(-) 13 2 3 3 1 02 33 3 82 53 3
T 14 113 127 85 42 127 93 34 127
k index (95% CI) 0.060 (-0.061–0.182) 0.455 (0.280–0.629) 0.655 (0.503–0.808)
EP PSLc8 P(+) 13 80 93 75 18 93 - - -
N(-) 13 3 3 4 1 02 43 4
T 14 113 127 85 42 127
k index (95% CI) 0.064 (-0.059–0.186) 0.477 (0.306–0.648)
EP PSLc6 P(+) 11 74 85 - - - -
N(-) 33 9 4 2
T 14 113 127
k index (95% CI) 0.041 (-0.094–0.175)
Samples from L. infantum-infected dogs (n=107) and healthy dogs (n=20) were tested. P: positive; N: negative; T: total; CI: confidence interval;
*cut off obtained according to the manufacturer;
#cut off obtained by ROC curve using 20 control serum samples.
doi:10.1371/journal.pntd.0001310.t003
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the real importance of cross-reactivity with these trypanosomatids
in EP tests.
The existence of false positives related to these tripanossomatids
(L. braziliensis and T. cruzi) raises the suspicion of cross reaction
with another parasites with higher prevalence in urban dogs, such
as Ehrlichia canis and Babesia canis. Further investigation will be
necessary in order to characterize the occurrence of potential cross
reactions in EP.
Recent studies have evaluated multiple-epitope chimeric
antigens as diagnostic markers for the serodiagnosis of CVL
[26,44], which represents an interesting approach to our peptides.
The development of an immunochromatographic strip would also
be desirable, as it is a common approach in the diagnosis of CVL
(rK39 strips) and other pathologies [45–47]. It would be
interesting to combine multiple peptides to improve the accuracy,
as CHEMBIO has done with the DPP
TM immunochromato-
graphic test that employs recombinant antigens K39 and K26 to
diagnose CVL. It is feasible to use in the same strip test an antigen
with good sensitivity and another with good specificity. Taken
together, to improve the diagnostic specificity preventing the
unnecessary culling of dogs, some alternatives employing the
synthetic peptides should be further investigated. For example,
structural changes in the antigens, such as the production of
conjugated peptides would be an interesting approach in order to
increase both sensitivity and specificity.
In conclusion, we have designed new synthetic peptides for the
improved serodiagnosis of CVL. The synthetic peptides named
PSLc6, PSLc8, PSLc10 and Mix10 afforded high accuracy in
detecting CVL cases and are faster and cheaper to produce. Our
findings indicate that synthetic peptides will be useful for serodiag-
nosis and allow for the detection of asymptomatic dogs. The
development of an immunochromatographic test using thesepeptides
would be a valuabletool for the rapid diagnosis of CVL, an important
issue for the control of this neglected disease in endemic areas.
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